Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

The Prognosis of Acute Myocardial Infarction in Xinjiang

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02737956
Recruitment Status : Unknown
Verified April 2016 by Xiang Xie, Xinjiang Medical University.
Recruitment status was:  Enrolling by invitation
First Posted : April 14, 2016
Last Update Posted : April 14, 2016
Sponsor:
Information provided by (Responsible Party):
Xiang Xie, Xinjiang Medical University

Brief Summary:
This study is to build a Xinjiang people registry and surveillance system for acute myocardial infarction(AMI) in2012-2015years to obtain real-world information about patient's basic information, patient characteristics, diagnostic test mode, the program of treatment and hospitalization outcomes including mortality, treatment complications, the cost of hospitalization and follow-up terminal events (death, major adverse cardiac events, minor adverse cardiovascular events)of xinjiang AMI patients; And to propose scientific precaution strategies aimed to prevent effectively from the incidence of AMI; And to optimize the management and outcomes of AMI patients through implementation of guideline recommendations in clinical practice, and analysis and development of effective treatment strategies; And to create cost-effective assessment system.

Condition or disease
Acute Myocardial Infarction

Detailed Description:
The aim of the study is to establish the platform for surveillance, clinical research and translational medicine in Xinjiang , designed to provide a foundation for future quality improvement and research as well as facilitate efforts to improve the quality of AMI patient care , translate research into improved care for patients and thus decrease morbidity and mortality associated with AMI.

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 1858 participants
Observational Model: Case-Only
Target Follow-Up Duration: 38 Months
Study Start Date : March 2016
Estimated Primary Completion Date : June 2016
Estimated Study Completion Date : June 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Attack




Primary Outcome Measures :
  1. All-cause mortality [ Time Frame: 38 months of follow-up deaths occurred during this period ]

Secondary Outcome Measures :
  1. Major adverse cardiovascular events(cardiac death、 myocardial infarction again、target vessel revascularization、deterioration of cardiac function、readmission) [ Time Frame: 38 months of follow-up major adverse cardiovascular events occurred during this period ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Acute myocardial infarction patients in hospitalized of The First Affiliated Hospital of Xinjiang Medical (include diagnosed acute ST-elevation or non ST-elevation myocardial infarction)
Criteria

Inclusion Criteria:

  • Acute myocardial infarction patients in hospitalized of The First Affiliated Hospital of Xinjiang Medical (include diagnosed acute ST-elevation or non ST-elevation myocardial infarction).Diagnosis criteria must meet Universal Definition for AMI (2012).

Exclusion Criteria:

  • Myocardial infarction related to percutaneous coronary intervention

Additional Information:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Xiang Xie, Xiangxie, MD,The First Affiliated Hospital Of XinJiang Medicial University, Xinjiang Medical University
ClinicalTrials.gov Identifier: NCT02737956    
Other Study ID Numbers: 20160317-03
First Posted: April 14, 2016    Key Record Dates
Last Update Posted: April 14, 2016
Last Verified: April 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Myocardial Infarction
Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases